These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 31936346)

  • 21. Multidrug resistance in prostate cancer.
    van Brussel JP; Mickisch GH
    Onkologie; 2003 Apr; 26(2):175-81. PubMed ID: 12771527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
    Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
    Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer potential of Thevetia peruviana fruit methanolic extract.
    Ramos-Silva A; Tavares-Carreón F; Figueroa M; De la Torre-Zavala S; Gastelum-Arellanez A; Rodríguez-García A; Galán-Wong LJ; Avilés-Arnaut H
    BMC Complement Altern Med; 2017 May; 17(1):241. PubMed ID: 28464893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Treatment by Using Traditional Chinese Medicine: Probing Active Compounds in Anti-multidrug Resistance During Drug Therapy.
    Lou JS; Yao P; Tsim KWK
    Curr Med Chem; 2018; 25(38):5128-5141. PubMed ID: 28933300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nigericin decreases the viability of multidrug-resistant cancer cells and lung tumorspheres and potentiates the effects of cardiac glycosides.
    Yakisich JS; Azad N; Kaushik V; O'Doherty GA; Iyer AK
    Tumour Biol; 2017 Mar; 39(3):1010428317694310. PubMed ID: 28351327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overcoming multidrug resistance in human lung cancer with novel benzo[a]quinolizin-4-ones.
    Kanintronkul Y; Worayuthakarn R; Thasana N; Winayanuwattikun P; Pattanapanyasat K; Surarit R; Ruchirawat S; Svasti J
    Anticancer Res; 2011 Mar; 31(3):921-7. PubMed ID: 21498714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
    PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative determination of tumor platinum concentration of patients with advanced Breast, lung, prostate, or colorectal cancers undergone platinum-based chemotherapy.
    Mostaghimi H; Mehdizadeh AR; Jahanbakhsh M; Dehghanian AR; Askari R
    J Cancer Res Ther; 2017; 13(6):930-935. PubMed ID: 29237953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
    Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
    Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin.
    Li H; Krstin S; Wink M
    Phytomedicine; 2018 Nov; 50():213-222. PubMed ID: 30466981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
    Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
    Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPGS/Phospholipids Mixed Micelles for Delivery of Icariside II to Multidrug-Resistant Breast Cancer.
    Song J; Huang H; Xia Z; Wei Y; Yao N; Zhang L; Yan H; Jia X; Zhang Z
    Integr Cancer Ther; 2016 Sep; 15(3):390-9. PubMed ID: 26293804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
    Scarbrough PM; Weber RP; Iversen ES; Brhane Y; Amos CI; Kraft P; Hung RJ; Sellers TA; Witte JS; Pharoah P; Henderson BE; Gruber SB; Hunter DJ; Garber JE; Joshi AD; McDonnell K; Easton DF; Eeles R; Kote-Jarai Z; Muir K; Doherty JA; Schildkraut JM
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):193-200. PubMed ID: 26637267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
    Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
    J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance.
    Zahra R; Furqan M; Ullah R; Mithani A; Saleem RSZ; Faisal A
    PLoS One; 2020; 15(6):e0233993. PubMed ID: 32484843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.
    Lorendeau D; Dury L; Genoux-Bastide E; Lecerf-Schmidt F; Simões-Pires C; Carrupt PA; Terreux R; Magnard S; Di Pietro A; Boumendjel A; Baubichon-Cortay H
    Biochem Pharmacol; 2014 Aug; 90(3):235-45. PubMed ID: 24875445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.